Design of RESILIENCE: A Phase 3 Trial Comparing Capecitabine in Combination With Sorafenib or Placebo for Treatment of Locally Advanced or Metastatic HER2-negative Breast Cancer
Breast Cancer Research - United Kingdom
doi 10.1186/bcr3011
Full Text
Open PDFAbstract
Available in full text
Date
November 16, 2011
Authors
Publisher
Springer Science and Business Media LLC